These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 18803261)
1. Novel mucoadhesive extended release tablets for treatment of oral candidosis: "in vivo" evaluation of the biopharmaceutical performance. Llabot JM; Manzo RH; Allemandi DA J Pharm Sci; 2009 May; 98(5):1871-6. PubMed ID: 18803261 [TBL] [Abstract][Full Text] [Related]
2. Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination. de Aguiar MM; de Albuquerque RP; Marinho DS; Braga BR; Dornelas CB; Oliveira A; de Sousa VP; Torres SR; Alviano DS; Alviano CS; Cabral LM; Holandino C Drug Dev Ind Pharm; 2010 May; 36(5):594-600. PubMed ID: 19954405 [TBL] [Abstract][Full Text] [Related]
3. Development of purified cashew gum mucoadhesive buccal tablets containing nystatin for treatment of oral candidiasis. Magalhães APSPA; Toma HK; do Carmo FA; Mansur CRE Drug Dev Ind Pharm; 2021 May; 47(5):825-837. PubMed ID: 34033502 [TBL] [Abstract][Full Text] [Related]
4. Nystatin pastilles and suspension in the treatment of oral candidosis. Millns B; Martin MV Br Dent J; 1996 Sep; 181(6):209-11. PubMed ID: 8885454 [TBL] [Abstract][Full Text] [Related]
6. Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets. Sakeer K; Al-Zein H; Hassan I; Martin GP; Nokhodchi A Pharm Dev Technol; 2010; 15(4):360-8. PubMed ID: 19772376 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of dissolution of nystatin from buccoadhesive tablets containing various surfactants and a solid dispersion formulation. Sakeer K; Al-Zein H; Hassan I; Desai S; Nokhodchi A Arch Pharm Res; 2010 Nov; 33(11):1771-9. PubMed ID: 21116780 [TBL] [Abstract][Full Text] [Related]
8. Design and fungicidal activity of mucoadhesive lactoferrin tablets for the treatment of oropharyngeal candidosis. Kuipers ME; Heegsma J; Bakker HI; Meijer DK; Swart PJ; Frijlink EW; Eissens AC; de Vries-Hospers HG; van den Berg JJ Drug Deliv; 2002; 9(1):31-8. PubMed ID: 11839206 [TBL] [Abstract][Full Text] [Related]
9. Research studies on the quality of bio-mucoadhesive tablets containing miconazole nitrate. Birsan M; Popovici I; Palade L; Cojocaru I Rev Med Chir Soc Med Nat Iasi; 2013; 117(1):257-62. PubMed ID: 24505925 [TBL] [Abstract][Full Text] [Related]
10. Salivary nystatin concentrations after administration of an osmotic controlled release tablet and a pastille. Encarnacion M; Chin I Eur J Clin Pharmacol; 1994; 46(6):533-5. PubMed ID: 7995321 [TBL] [Abstract][Full Text] [Related]
11. Nystatin and lidocaine pastilles for the local treatment of oral mucositis. Silva FC; Marto JM; Salgado A; Machado P; Silva AN; Almeida AJ Pharm Dev Technol; 2017 Mar; 22(2):266-274. PubMed ID: 27499389 [TBL] [Abstract][Full Text] [Related]
12. [Mucoadhesive tablets for oral administration of ciclopiroxolamine]. Kuna M; Rabisková M Ceska Slov Farm; 2007 Oct; 56(5):243-8. PubMed ID: 18064806 [TBL] [Abstract][Full Text] [Related]
13. Evolution of saliva and serum components in patients with oral candidosis topically treated with Ketoconazole and Nystatin. Cornejo LS; López de Blanc S; Femopase F; Azcurra A; Calamari S; Battellino LJ; Dorronsoro de Cattoni ST Acta Odontol Latinoam; 1998; 11(1):15-25. PubMed ID: 11885450 [TBL] [Abstract][Full Text] [Related]
14. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies. Aksungur P; Sungur A; Unal S; Iskit AB; Squier CA; Senel S J Control Release; 2004 Aug; 98(2):269-79. PubMed ID: 15262418 [TBL] [Abstract][Full Text] [Related]
15. Fluconazole versus nystatin in the treatment of oral candidosis. Blomgren J; Berggren U; Jontell M Acta Odontol Scand; 1998 Aug; 56(4):202-5. PubMed ID: 9765010 [TBL] [Abstract][Full Text] [Related]
16. Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: ultrastructural effects and release studies. Fernández Campos F; Calpena Campmany AC; Rodríguez Delgado G; López Serrano O; Clares Naveros B J Pharm Sci; 2012 Oct; 101(10):3739-52. PubMed ID: 22777575 [TBL] [Abstract][Full Text] [Related]
17. Development and in vitro evaluation of a mucoadhesive vaginal delivery system for nystatin. Hombach J; Palmberger TF; Bernkop-Schnürch A J Pharm Sci; 2009 Feb; 98(2):555-64. PubMed ID: 18563796 [TBL] [Abstract][Full Text] [Related]
18. Clinical use of oral nystatin in the prevention of systemic candidosis in patients at particular risk. Schäfer-Korting M; Blechschmidt J; Korting HC Mycoses; 1996; 39(9-10):329-39. PubMed ID: 9009654 [TBL] [Abstract][Full Text] [Related]
19. Role of cyclodextrin complexation in felodipine-sustained release matrix tablets intended for oral transmucosal delivery: in vitro and ex vivo characterization. Palem CR; Kumar Battu S; Gannu R; Yamsani VV; Repka MA; Yamsani MR Pharm Dev Technol; 2012; 17(3):321-32. PubMed ID: 21265709 [TBL] [Abstract][Full Text] [Related]
20. Design and in vitro/in vivo evaluation of novel mucoadhesive buccal discs of an antifungal drug: relationship between swelling, erosion, and drug release. Yehia SA; El-Gazayerly ON; Basalious EB AAPS PharmSciTech; 2008; 9(4):1207-17. PubMed ID: 19082739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]